Although individuals older than 80 years make up more than 20% of cases of chronic lymphocytic leukemia (CLL), this population is underrepresented in clinical drug trials, and data on treatment outcomes are limited. At the 63rd American Society of Hematology (ASH) Annual Meeting & Exhibition, researchers presented results from a pooled analysis of phase II … Continue reading Study Finds First-Line Targeted Treatment for CLL Is Beneficial in Elderly Patients